Quick Answer
BIOVIE INC. reported Operating Income Loss of -$18.07 million for the year ending 2025.
- BIOVIE INC. showed an increase of +43.9% in Operating Income Loss from 2024 to 2025.
- This data is from BIOVIE INC.'s annual report (Form 10-K), filed with the SEC on August 15, 2025.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: -$54.6 thousand | Q4 2015: -$49.9 thousand | Q1 2016: -$57.9 thousand | Q3 2016: -$351.4 thousand | Q4 2016: -$357.8 thousand | Q1 2017: -$400.5 thousand | Q3 2017: -$662.2 thousand | Q4 2017: -$494.8 thousand | Q1 2018: -$691.2 thousand | Q3 2018: -$491.4 thousand | Q4 2018: -$500.9 thousand | Q1 2019: -$848.3 thousand | Q3 2019: -$706.2 thousand | Q4 2019: -$710.4 thousand | Q1 2020: -$699.3 thousand | Q3 2020: -$386.8 thousand | Q4 2020: -$3.06 million | Q1 2021: -$3.00 million | Q3 2021: -$5.55 million | Q4 2021: -$6.67 million | Q1 2022: -$5.75 million | Q3 2022: -$8.83 million | Q4 2022: -$11.49 million | Q1 2023: -$13.77 million | Q3 2023: -$10.88 million | Q4 2023: -$8.78 million | Q1 2024: -$7.73 million | Q3 2024: -$4.12 million | Q4 2024: -$7.29 million | Q1 2025: -$2.99 million | Q3 2025: -$5.28 million | Q4 2025: -$6.26 million.
- Over the full 11 years of available data (2015 to 2025), BIOVIE INC.'s Operating Income Loss has declined by 7,641.2%.
- Historical annual values: Fiscal year 2025: -$18.07 million | Fiscal year 2024: -$32.18 million | Fiscal year 2023: -$45.08 million | Fiscal year 2022: -$27.25 million | Fiscal year 2021: -$138.05 million | Fiscal year 2020: -$2.69 million | Fiscal year 2019: -$2.50 million | Fiscal year 2018: -$2.37 million | Fiscal year 2017: -$1.55 million | Fiscal year 2016: -$432.0 thousand | Fiscal year 2015: -$233.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: